We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATO icon
2301
Cato Corp
CATO
$65.7M
$132K ﹤0.01%
7,694
– –
KBAL
2302
DELISTED
Kimball International
KBAL
$132K ﹤0.01%
12,880
+6,164
+92% +$66.7K
AFCG
2303
AFC Gamma
AFCG
$64.3M
$132K ﹤0.01%
+8,453
New +$132K
ALTO icon
2304
Alto Ingredients
ALTO
$315M
$131K ﹤0.01%
27,235
– –
KNSA icon
2305
Kiniksa Pharmaceuticals
KNSA
$6.1B
$130K ﹤0.01%
11,087
– –
ERAS icon
2306
Erasca
ERAS
$6.5B
$130K ﹤0.01%
8,360
– –
ATRS
2307
DELISTED
Antares Pharma, Inc.
ATRS
$130K ﹤0.01%
36,430
-23,939
-40% -$83.7K
CTO
2308
CTO Realty Growth
CTO
$819M
$130K ﹤0.01%
6,327
– –
UTMD icon
2309
Utah Medical Products
UTMD
$230M
$129K ﹤0.01%
1,293
– –
RUSHB icon
2310
Rush Enterprises Class B
RUSHB
$9.18B
$129K ﹤0.01%
3,582
– –
PLRX icon
2311
Pliant Therapeutics
PLRX
$66.3M
$128K ﹤0.01%
9,508
– –
INDT
2312
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$128K ﹤0.01%
1,581
– –
INST
2313
DELISTED
Instructure Holdings, Inc.
INST
$128K ﹤0.01%
5,336
– –
FRST icon
2314
Primis Financial Corp
FRST
$411M
$128K ﹤0.01%
8,503
+4,967
+140% +$75.4K
TOON icon
2315
Kartoon Studios
TOON
$38.7M
$128K ﹤0.01%
12,163
– –
CIVB icon
2316
Civista Bancshares
CIVB
$597M
$128K ﹤0.01%
5,230
+1,766
+51% +$43.4K
BTAI icon
2317
BioXcel Therapeutics
BTAI
$32.7M
$128K ﹤0.01%
392
– –
UDMY
2318
DELISTED
Udemy
UDMY
$127K ﹤0.01%
+6,474
New +$155K
AXTI icon
2319
AXT Inc
AXTI
$5.13B
$126K ﹤0.01%
14,329
+10,521
+276% +$89K
EOSE icon
2320
Eos Energy Enterprises
EOSE
$1.54B
$126K ﹤0.01%
16,761
– –
OSBC icon
2321
Old Second Bancorp
OSBC
$1.31B
$126K ﹤0.01%
9,998
– –
RCEL icon
2322
Avita Medical
RCEL
$251M
$125K ﹤0.01%
10,458
– –
RDUS
2323
DELISTED
Radius Health, Inc.
RDUS
$125K ﹤0.01%
18,090
+6,895
+62% +$101K
RYAM icon
2324
Rayonier Advanced Materials
RYAM
$561M
$125K ﹤0.01%
21,822
+9,907
+83% +$64.4K
TTI icon
2325
TETRA Technologies
TTI
$1.29B
$124K ﹤0.01%
43,695
+24,875
+132% +$76.7K
91 92
93
94 95

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.